Roivant Sciences
Price & Volume
Stats
See more52W Range | $9.69-$13.05 |
Market Cap | $8.4B |
Shares Short | 47M |
Financials
See moreRevenue (12 Mos) | $129.1M |
Revenue Growth (YoY) | 22.7% |
Gross Profit (12 Mos) | -$477M |
Diluted EPS | $5.54 |
News
See moreYahoo Finance • 3 months ago
Is Roivant Sciences Ltd. (ROIV) the Best Guru Stock To Buy Now?
Yahoo Finance • 3 months ago
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
Yahoo Finance • 3 months ago
Roivant Sciences Unveils New 'Vant' Subsidiary For In-Licensed Pulmonary Hypertension Drug From Bayer
Yahoo Finance • 4 months ago
The Federal Reserve should refresh its mandate: Former presidential candidate Vivek Ramaswamy
About
CEO | Mr. Matthew Gline |
Address | 50 Broadway, London, United Kingdom, SW1H 0DB |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 908 |
